Outlook Therapeutics, Inc. (OTLK)
0.6405
-0.03
(-3.90%)
USD |
NASDAQ |
Sep 08, 16:00
0.6447
0.00 (0.00%)
Pre-Market: 08:35
Outlook Therapeutics Total Liabilities (Quarterly) : 36.58M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 36.58M |
| March 31, 2026 | 50.89M |
| December 31, 2025 | 56.79M |
| June 30, 2025 | 59.58M |
| March 31, 2025 | 51.54M |
| December 31, 2024 | 67.30M |
| September 30, 2024 | 101.90M |
| June 30, 2024 | 130.77M |
| March 31, 2024 | 193.26M |
| December 31, 2023 | 46.03M |
| September 30, 2023 | 46.74M |
| June 30, 2023 | 49.95M |
| March 31, 2023 | 43.54M |
| December 31, 2022 | 46.93M |
| September 30, 2022 | 19.79M |
| June 30, 2022 | 18.51M |
| March 31, 2022 | 31.72M |
| December 31, 2021 | 29.85M |
| September 30, 2021 | 18.20M |
| June 30, 2021 | 20.13M |
| March 31, 2021 | 24.46M |
| Date | Value |
|---|---|
| December 31, 2020 | 22.99M |
| September 30, 2020 | 16.91M |
| June 30, 2020 | 19.28M |
| March 31, 2020 | 33.69M |
| December 31, 2019 | 35.83M |
| September 30, 2019 | 27.90M |
| June 30, 2019 | 34.57M |
| March 31, 2019 | 40.22M |
| December 31, 2018 | 40.18M |
| September 30, 2018 | 43.09M |
| June 30, 2018 | 43.35M |
| March 31, 2018 | 43.06M |
| December 31, 2017 | 40.17M |
| September 30, 2017 | 51.46M |
| June 30, 2017 | 46.07M |
| March 31, 2017 | 44.31M |
| December 31, 2016 | 42.28M |
| September 30, 2016 | 28.91M |
| June 30, 2016 | 31.43M |
| March 31, 2016 | 45.30M |
| December 31, 2015 | 45.87M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Valion Bio, Inc. | 20.59M |
| Agenus, Inc. | 378.54M |
| Amgen, Inc. | 83.95B |
| Anika Therapeutics, Inc. | 46.19M |
| BioCryst Pharmaceuticals, Inc. | 1.012B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 26.18M |
| Shareholders Equity (Quarterly) | -10.39M |
| Debt to Equity Ratio | -1.774 |
| Current Ratio | 0.8078 |
| Net Debt Paydown Yield | 0.85% |